Pediatric relapsed/refractory ALK-positive anaplastic large cell lymphoma treatment and outcomes in the targeted-drug era

Lianna J. Marks, Catherine Aftandilian, Jennifer E. Agrusa et al.|Blood Advances|2025

Cited by 9